Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Therapies that use stem cells to repair or replace damaged cells in the brains of patients with Parkinson’s disease have been ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

Two studies published in Nature found stem-cell derived products can not only be safely transplanted into the brain, but also ...

New hope as surprising Parkinson’s treatment deemed safe in clinical trials - More than 150,000 people in the UK are living ...

The regenerative role of the adult stem cell secretome is a burgeoning area of research with significant therapeutic potential. These secretomes, which ...

Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...

Scientists at Japan's Keio University have pioneered a stem cell therapy that enables paralyzed individuals to regain motor function. This groundbreaking treatment using induced pluripotent stem ...

After 3.5 years of follow-up, there was a 98% rate of minimal residual disease, and 9 patients were still in complete remission.

Stem cells used or targeted by cell therapy can be grouped into three categories: pluripotent stem cells (PSCs), adult stem cells (ASCs), and cancer stem cells (CSCs). Stem cell transplant is ...

They can also help repair or rebuild damaged cells. Medicare covers stem cell therapy for specific uses, mostly for treating certain types of cancer or bleeding disorders, such as sickle cell disease.

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.